EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma.
Ruf
I K
IK
Program in Viral Oncogenesis and Tumor Immunology, Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Rhyne
P W
PW
Yang
H
H
Borza
C M
CM
Hutt-Fletcher
L M
LM
Cleveland
J L
JL
Sample
J T
JT
D017209:Apoptosis; D002051:Burkitt Lymphoma / Q000378:metabolism* / Q000473:pathology* / Q000821:virology; D002470:Cell Survival; D019309:Epstein-Barr Virus Nuclear Antigens / Q000378:metabolism; D005786:Gene Expression Regulation; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D017735:Virus Latency
D019309:Epstein-Barr Virus Nuclear Antigens; D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc; C417029:EBV-encoded nuclear antigen 1